Macrophage-targeted photodynamic therapy

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 2, 2004, Pages 117-126

  Demidova, T N ^a   Hamblin, M R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atherosclerosis; Cancer; Inflammation; Macrophages; Photosensitizer conjugate

Indexed keywords

LIGAND; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR;

ANTIGEN RECOGNITION; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNE DISEASE; CANCER THERAPY; CELL COMPARTMENTALIZATION; CELL KILLING; CELL TYPE; CONJUGATE; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; DRUG TARGETING; ENDOCYTOSIS; ILLUMINATION; INFECTION; MACROMOLECULE; MACROPHAGE; MACROPHAGE TARGETED PHOTODYNAMIC THERAPY; MONOCYTE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; TISSUE NECROSIS;

EID: 8344273856     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700203     Document Type: Review

References (45)

1. Dolmans D.E., D. Fukumura and R.K. Jain. 2003. Photodynamic therapy for cancer. Nat. Rev. Cancer. 3:380.
2. Dougherty T.J. 2002. An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20:3.
3. Ochsner M. 1997. Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol. B. 39:1.
4. Ando T., K. Irie, K. Koshimizu, T. Takemura, H. Nishino, A. Iwashima, N. Takeda, S. Nakajima and I. Sakata. 1993. Photocytotoxicity of water-soluble metalloporphyrin derivatives. Photochem. Photobiol. 57:629.
5. Niedre M., M.S. Patterson and B.C. Wilson. 2002. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem. Photobiol. 75:382.
6. Georgakoudi I., M.G. Nichols and T.H. Foster. 1997. The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem. Photobiol. 65:135.
7. Hasan T. 1992. Photosensitizer delivery mediated by macromolecular carrier systems. In Photodynamic therapy: Basic principles and clinical applications. B. W. Henderson and T. J. Dougherty, ed. Marcel Dekker New York, p. 187.
8. Noguchi Y., J. Wu, R. Duncan, J. Strohalm, K. Ulbrich, T. Akaike and H. Maeda. 1998. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn. J. Cancer Res. 89:307.
9. Rihova B. 1997. Targeting of drugs to cell surface receptors. Crit. Rev. Biotechnol. 17:149.
10. Winston B.W., P.M. Krein, C. Mowat and Y. Huang. 1999. Cytokine-induced macrophage differentiation: a tale of 2 genes. Clin. Invest. Med. 22:236.
11. DiPietro L. 1995. Wound healing: the role of the macrophage and other immune cells. Shock. 4:233.
12. Parthasarathy S., D. Steinberg and J.L. Witztum. 1992. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Ann. Rev. Med. 43:219.
13. Casscells W., B. Hathorn, M. David, T. Krabach, W.K. Vaughn, H.A. McAllister, G. Bearman and J.T. Willerson. 1996. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 347:1447.
14. Falk E. 1992. Why do plaques rupture? Circulation 86:11130.
15. Mantovani A. 1994. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest. 71:5.
16. Van Rooijen N. 1989. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Meth. 124:1.
17. Hamblin M.R., J.L. Miller and B. Ortel. 2000. Scavenger-receptor targeted photodynamic therapy. Photochem. Phothobiol. 72:533.
18. Murakami T. and N. Yamada. 1996. Modification of macrophage function and effects on atherosclerosis. Curr. Opin. Lipidol. 7:320.
19. Yamada Y., T. Doi, T. Hamakubo and T. Kodama. 1998. Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell Mol. Life Sci. 54:628.
20. Mukhopadhyay A., B. Mukhopadhyay and S.K. Basu. 1995. Circumvention of multidrug resistance in neoplastic cells through scavenger receptor mediated drug delivery. FEBS Lett. 376:95.
21. Krieger M. 1992. Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor. Trends Biochem. Sci. 17:141.
22. Mantovani A., S. Sozzani, M. Locati, P. Allavena and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549.
23. Wu S., C.M. Boyer, R.S. Whitaker, A. Berchuck, J.R. Wiener, J.B. Weinberg and R.C. Bast, Jr. 1993. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction oltumor cell proliferation and tumor necrosis factor alpha expression. Cancer Res. 53:1939.
24. O'Sullivan C., C.E. Lewis, A.L. Harris and J.O. McGee. 1993. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342:148.
25. Harmey J.H., E. Dimitriadis, E. Kay, H.P. Redmond and D. Bouchier-Hayes. 1998. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann. Surg. Oncol. 5:271.
26. Yoshino H., Y. Endo, Y. Watanabe and T. Sasaki. 1998. Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis. Br. J. Cancer 78:833.
27. Fairlie W.D., A.G. Moore, A.R. Bauskin, P.K. Russell, H.P. Zhang and S.N. Breit. 1999. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J. Leukoc. Biol. 65:2.
28. Wahl L.M. and H.K. Kleinman. 1998. Tumor-associated macrophages as targets for cancer therapy. J. Natl. Cancer Inst. 90:1583.
29. Korbelik M. and G. Krosl. 1996. Photofrin accumulation in malignant and host cell populations of various tumours. Br. J. Cancer 73:506.
30. Korbelik M. and G. Krosl. 1995. Photofrin accumulation in malignant and host cell populations of a murine fibrosarcoma. Phoiochem. Photobiol. 62:162.
31. Korbelik M., V.R. Naraparaju and N. Yamamoto. 1997. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br. J. Cancer 75:202.
32. Krosl G., M. Korbelik, J. Krosl and G.J. Dougherty. 1996. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res. 56:3281.
33. Hamblin M.R., D.A. O'Donnell, M. Huzaira and T. Zahra. 2002. Scavenger receptor-targeted photodynamic therapy of J774 tumors in mice: tumor response and concomitant immunity. Proc. S.P.I.E. 4617:1.
34. Forrester J.S. 2002. Prevention of plaque rupture: a new paradigm of therapy. Ann. Intern. Med. 137:823.
35. Muller J.E., G.S. Abela, R.W. Nesto and G.H. Toiler. 1994. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J. Am. Coll. Cardiol. 23:809.
36. Shah P.K., E. Falk, JJ. Badimon, A. Fernandez-Ortiz, A. Mailhac, G. Villareal-Levy, J.T. Fallen, J. Regnstrom and V. Fuster. 1995. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92:1565.
37. Constantinides P. and R.N. Chakravati. 1961. Rabbit arterial thrombosis production by systemic procedures. Arch. Pathol. 72:197.
38. Rockson S.G., O.P. Lorenz, W.F. Cheongand K.W. Woodburn. 2000. Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy. Circulation 102:591.
39. Hamblin M.R. and E.L. Newman. 1994. On the mechanism of the tumour-localising effect in photodynamic therapy. J. Photochem. Photobiol B. 23:3.
40. Hamblin M.R., A. Tawakol, A.P. Castano, F. Gad, T. Zahra, A. Ahmadi, J. Stern, B. Ortel, S. Chirico, A. Shirazi, S. Syed and J.E. Muller. 2003. Macrophage-targeted photodynamic detection of vulnerable atherosclerotic plaque. Proc. SPIE 4949:466.
41. Plutzky J. 1999. Atherosclerotic plaque rupture: emerging insights and opportunities. Am. J. Cardiol. 84:15J.
42. Amer A.O. and M.S. Swanson. 2002. A phagosome of one's own: a microbial guide to life in the macrophage. Curr. Opin. Microbiol. 5:56.
43. Stafford J.L., N.F. Neumann and M. Belosevic. 2002. Macrophage-mediated innate host defense against protozoan parasites. Crit. Rev. Microbiol. 28:187.
44. Ismail N., J.P. Olano, H.M. Feng and D.H. Walker. 2002. Current status of immune mechanisms of killing of intracellular microorganisms. FEMS Microbiol. Lett. 207:111.
45. Sansonetti P. 2002. Host-pathogen interactions: the seduction of molecular cross talk. Gut 50 (S3):1112.